homecontact us214-855-0077






Based on the citizen repetition submitted in February, 2005, the Food and Drug Administration (FDA) has directed drug manufacturers to make labeling changes to Ibuprofen and other non-steroidal anti-inflammatory drugs that include additional warnings regarding the risks of Stevens - Johnson syndrome (SJS), and Toxic Epidermal Necrolysis (TEN).

We  tirelessly supported the citizen petition filed with the FDA to make the public aware of the possible risks related to these drugs and SJS/TEN.



 The document is available on the FDA website in HTML and PDF format at: